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Kathleen O'Dowd, RN, BSN
Problem Identification and Description of 
Need 
• After discussing local doctors and nurses, I decided that HPV would be a good 
topic to talk about with the high school students because they are within the age 
range for vaccine eligibility, are most likely younger than the age group (females 
20-24y/o) that has the highest prevalence of HPV infection, and they can educate 
their peers on HPV and HPV vaccination.  
• After discussing with a local nurse, I realized that there is a need for HPV 
education within the student body of Danbury High School because many 
students do not see physicians regularly and the students are only required to 
take 1 semester of health class; both of which are settings where the students 
may be educated about HPV, the complications of an unresolved HPV infection, 
methods of reducing HPV transmission, and HPV vaccinations.
Public Health Cost and Unique Cost 
Considerations in Host Communities 
Nationally
• HPV is the most prevalent sexually transmitted infection in the US
• About 79 million people in the US are currently infected, with 14 million people newly infected 
yearly
• 75-80% of sexually active adults will have a genital HPV infection by the time they turn 50 years 
old
• New diagnosis of HPV-provoked cancers annually is 26,900: 10,400 cases of cervical cancer, 4,000 
cases of anal cancer, 9,000 cases of oropharyngeal cancer, 700 cases of penile cancer, 600 cases of 
vaginal cancer, and 2,200 cases of vulvar cancer.
Connecticut
• HPV vaccination is not a mandated vaccine for school
• CT has an estimated 37.7-44.9% vaccination rate in females ages 13-17 as of 2013
• Cancer Rates due to HPV per 100,000 as of 2006-2010 in Connecticut 
• Cervical cancer 4.37-6.65, vulvar cancer 0.99-1.86, vaginal cancer 0.41-0.47, penile cancer 
0.71-0.85, anal cancer in males 0.95-1.12, anal cancer in females 0.94-1.60, oropharyngeal 
cancer in males 5.62-6.34, oropharyngeal cancer in females 0.73-1.35, 
Community Perspective on Issue and Support 
for Project (2 interviews) 4a
Local Nurse:
• “I think the education piece for HPV is key because a lot of these students don’t have 
annual physical exams where they can discuss HPV with their doctor or even be offered 
the HPV vaccine.  Connecticut only requires annual physicals for entry into Kindergarten, 
6th grade, and 9th grade and for some of our students, these are the only times they see a 
doctor.”
• “I think educating the students on the prevalence, severity, and complications of an HPV 
infection is very important because a lot of these students think ‘this will never happen 
to me’ or have not even given HPV the time of day because it is not a mandated vaccine 
for school.”  
Community Perspective on Issue and Support 
for Project  (2 interviews) 4b 
Local Nurse #2:
• “It is a no-brainer vaccine.  It is an anti-cancer vaccine.  Parents need to understand that they 
have to give it to their children now in order to protect them in the future when they are in 
their 40s-60s.”
• “The biggest obstacle I face when recommending the vaccine is with the parents.  In many 
cases, the parents are making the decisions for these young children and the parents also 
need to be educated about HPV.  They need to know that HPV can be a serious infection.  
They need to know that there is no data suggesting that the HPV vaccine will make their kids 
become sexually active at a younger age.  There should not be any hesitancy with this 
vaccine.  The parents and children really need to be educated on HPV and the HPV vaccine so 
that they understand how important this vaccine really is.” 
Intervention and Methodology (5a) 
• My main objective was to educate high school students (students who are 
in the age range for the HPV vaccine) about HPV infections and why HPV 
infections should be taken seriously even though you may not show 
symptoms of an infection.
• I conducted a 20 minute presentation on HPV that educated the students 
on the following concepts: what HPV is, how HPV is spread, what people 
can do to reduce their risk of contracting HPV, HPV vaccination, and the 
complications of unresolved HPV infections.
• Students completed a pre and post interaction survey consisting of the 
same multiple choice questions regarding HPV.  This survey was used to 
assess how much the students learned during the presentation.  The post 
survey also contained questions about future presentation and directions.




Did you learn something 
today?
Definitely Somewhat Neutral





Are you more likely to talk 
to your friends about HPV?
Definitely Somewhat Neutral
Not Really Definitely Not
6
2
Would you like similar 
sessions on other STIs?
Yes No
• Students were given the pre-interaction and 
post-interaction surveys.
• All students completed the surveys.




















What is the most common STI in the 
US?
Pre-Interaction Post-Interaction
Evaluation of Effectiveness and limitations (7)
• My advisor and the High School Biology Teacher both expressed that the 
presentation was very relevant to the students and that it was a great way 
to introduce the students to the complications of HPV, ways to reduce HPV 
transmission, and HPV vaccination.
• Students were engaged, regularly asked questions, and all took HPV 
informational pamphlets.
• Students were a biased, pre-selected group as they were members of the 
Medicine Student Interest Group.  
• Limited sample size (8).  This may have been because it was the first day 
back from spring break and that i. students could still be away and ii. 
students either forgot the club was meeting that Monday and/or could not 
get a ride home after the club meeting (could only get a ride home 
immediately after school).   
Recommendations for future 
interventions/projects (8)
• Start targeting students at younger ages such as 9 which is the 
earliest age for male and female HPV vaccine eligibility.
• Start targeting parents because they are the ones primarily making 
the health care decisions for the younger children.  This can be done 
on Back to School nights, at local community centers such as the 
YMCA, in collaboration with local pediatricians and family medicine 
doctors, etc.
• Educate students and parents on where they can get the vaccine and 
what/if any financial support is available. 
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